Stocks and Investing Stocks and Investing
Thu, March 7, 2024

Robert Wasserman Reiterated (ATHE) at Buy and Held Target at $4 on, Mar 7th, 2024


Published on 2024-10-28 09:31:53 - WOPRAI, Robert Wasserman
  Print publication without navigation


Robert Wasserman of Benchmark, Reiterated "Alterity Therapeutics Limited" (ATHE) at Buy and Held Target at $4 on, Mar 7th, 2024.

Robert, nor any peers, have made any analyst calls on ATHE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources